NCT02822612

Brief Summary

Ophthalmology is among the most technology driven of all medical specialties, with advanced medical imaging devices - and specialised computer software - increasingly adopted for routine clinical use. While many such devices are capable of completing specific tasks, lack of "usability" prevents their widespread adoption (i.e., such devices are not easy to learn and remember, or are not efficient or subjectively pleasing to use). Moreover, devices that are difficult to use expose patients to clinical risk as a result of human error during usage. With the introduction of a new medical technology, it is essential, therefore, to have a deep understanding of patients, what they need, what they value, their abilities, and also their limitations. Human factor and usability testing, also known as "human factor engineering", deals with the formal study of people's interaction with their environment (in this case, the binocular optical coherence tomography (OCT) device). Structured, patient-centred, usability testing is essential to the design, clinical validation, regulatory approval, and widespread implementation, of all new medical devices. This is particularly the case for a putative binocular OCT system - a device intended for automated use in visually impaired, often elderly, populations. Although the binocular OCT is already at an advanced stage of hardware development, the EASE study will facilitate an iterative process of operating software and workflow modifications to optimize the device for use in these populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 4, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

March 26, 2020

Completed
Last Updated

March 26, 2020

Status Verified

March 1, 2020

Enrollment Period

5 months

First QC Date

June 23, 2016

Results QC Date

September 5, 2017

Last Update Submit

March 25, 2020

Conditions

Keywords

optical coherence tomographyoptical imagingretinal imaging

Outcome Measures

Primary Outcomes (1)

  • Total Examination Time

    Total time for each participant to complete the binocular optical coherence tomography (OCT) examination was calculated.

    6 months

Secondary Outcomes (2)

  • Number of Participants With Subjective Ratings ≥ 4 on Post-Test Questionnaire

    6 months

  • Number of Participants That Presented Gradable Data, by Examination Type

    4 months

Study Arms (4)

Retinal Disease

Fifteen subjects with retinal disease. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.

Device: Binocular OCT prototype

Glaucoma

Fifteen subjects with glaucoma. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.

Device: Binocular OCT prototype

Strabismus

Fifteen subjects with strabismus. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.

Device: Binocular OCT prototype

Healthy volunteers

Fifteen healthy volunteers. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.

Device: Binocular OCT prototype

Interventions

Testing will begin using a prototype binocular OCT system. Subjects will undergo the full suite of diagnostic assessments offered by the system at that time (i.e., visual acuity, ophthalmic history, pupillometry, ocular motility, perimetry, anterior segment and posterior segment OCT imaging).

GlaucomaHealthy volunteersRetinal DiseaseStrabismus

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with chronic eye disease (retinal disease, glaucoma, and strabismus) will be recruited from appropriate eye clinics at Moorfields Eye Hospital and from a patient advisory group established for this purpose.

You may qualify if:

  • Presence of retinal disease, glaucoma or strabismus
  • Male or female, aged 18 years or older
  • Ability to understand nature/purpose of the study and to provide informed consent
  • Ability to undergo binocular OCT imaging
  • Ability to follow instructions and complete the study
  • Ability to speak English

You may not qualify if:

  • Optical media opacity sufficient to preclude adequate ocular imaging with OCT
  • Hearing impairment sufficient to interfere with hearing instructions
  • Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.
  • No self-reported ocular history (although wearing corrective prescription glasses is permitted)
  • Male or female, aged 18 years or older
  • Ability to understand nature/purpose of the study and to provide informed consent
  • Ability to undergo binocular OCT imaging
  • Ability to follow instructions and complete the study
  • Ability to speak English
  • Presence of ocular pathology
  • Hearing impairment sufficient to interfere with hearing instructions
  • Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moorfields Eye Hospital NHS FT

London, EC1V 2PD, United Kingdom

Location

MeSH Terms

Conditions

GlaucomaRetinal DiseasesStrabismus

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesOcular Motility DisordersCranial Nerve DiseasesNervous System Diseases

Results Point of Contact

Title
Pearse Keane
Organization
Moorfields Eye Hospital NHS Foundation Trust

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2016

First Posted

July 4, 2016

Study Start

May 1, 2016

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

March 26, 2020

Results First Posted

March 26, 2020

Record last verified: 2020-03

Locations